Amundi’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-1,469,196
| Closed | -$111M | – | 2116 |
|
|
2026
Q1 | $111M | Buy |
1,469,196
+145,287
| +11% | +$10.9M | 0.03% | 427 |
|
|
2025
Q4 | $98.6M | Buy |
1,323,909
+253,754
| +24% | +$18.5M | 0.03% | 493 |
|
|
2025
Q3 | $72.1M | Sell |
1,070,155
-41,749
| -4% | -$2.77M | 0.02% | 477 |
|
|
2025
Q2 | $72.6M | Buy |
1,111,904
+26,970
| +2% | +$1.62M | 0.03% | 485 |
|
|
2025
Q1 | $66.9M | Sell |
1,084,934
-423,165
| -28% | -$28M | 0.02% | 493 |
|
|
2024
Q4 | $110M | Sell |
1,508,099
-57,873
| -4% | -$4.52M | 0.04% | 407 |
|
|
2024
Q3 | $126M | Buy |
1,565,972
+94,120
| +6% | +$7.53M | 0.05% | 348 |
|
|
2024
Q2 | $108M | Sell |
1,471,852
-552,929
| -27% | -$41.4M | 0.04% | 366 |
|
|
2024
Q1 | $152M | Buy |
2,024,781
+202,637
| +11% | +$15.1M | 0.07% | 292 |
|
|
2023
Q4 | $131M | Buy |
1,822,144
+113,239
| +7% | +$7.88M | 0.06% | 330 |
|
|
2023
Q3 | $118M | Buy |
1,708,905
+315,690
| +23% | +$23.9M | 0.06% | 332 |
|
|
2023
Q2 | $111M | Buy |
1,393,215
+263,729
| +23% | +$21.6M | 0.06% | 338 |
|
|
2023
Q1 | $92.7M | Sell |
1,129,486
-94,781
| -8% | -$7.63M | 0.05% | 373 |
|
|
2022
Q4 | $99.3M | Sell |
1,224,267
-107,796
| -8% | -$7.68M | 0.05% | 350 |
|
|
2022
Q3 | $88.2M | Buy |
1,332,063
+442,431
| +50% | +$30.6M | 0.05% | 365 |
|
|
2022
Q2 | $61.7M | Buy |
889,632
+58,451
| +7% | +$4.34M | 0.05% | 386 |
|
|
2022
Q1 | $66.1M | Buy |
831,181
+127,636
| +18% | +$9.18M | 0.04% | 404 |
|
|
2021
Q4 | $49.2M | Sell |
703,545
-126,201
| -15% | -$9.28M | 0.03% | 480 |
|
|
2021
Q3 | $61.2M | Buy |
829,746
+23,010
| +3% | +$1.73M | 0.04% | 409 |
|
|
2021
Q2 | $53.8M | Buy |
+806,736
| New | +$53.9M | 0.04% | 423 |
|
Other funds holding HOLX
Amundi's HOLX Position: Q2 2026 in Review
Amundi sold out of Hologic (HOLX) in Q2 2026, closing a stake of 1,469,196 shares — an estimated $111M sold.
Amundi first reported a position in HOLX in Q2 2021 and held it in 20 quarters. The position peaked at $152M in Q1 2024. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.
- Amundi reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
- Amundi sold 1,469,196 Hologic shares in Q2 2026, an estimated $111M.
- Amundi first reported a position in Hologic in Q2 2021 and held it in 20 quarters.
- Amundi's Hologic position peaked at $152M in Q1 2024.
- 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.
Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.